A Phase 2 randomised double blind study comparing tremelimumab to placebo in second or third treatment of subjects with unresectable pleural or peritonela malignant mesothelioma

Project: Research

Project Details

StatusFinished
Effective start/end date1/08/13 → 31/08/14

Clinical Trial Phase

  • Phase II